XOMA

XOMA Corporation

25.44 USD
+0.53 (+2.13%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

XOMA Corporation stock is down -4% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 37 May’s closed higher than April. 100% of analysts rate it a buy.

About XOMA Corporation

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets with commercial sales potential.

  • HC Wainwright & Co.
    Wed May 1, 07:02
    buy
    confirm
  • Leerink Partners
    Mon Apr 29, 08:45
    buy
    initial